Title : KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients.

Pub. Date : 2013 Jan 15

PMID : 23175150






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
2 BACKGROUND: In this study, we evaluated the possibility that KRAS mutational status might be predictive of oxaliplatin (OXA) efficacy. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
3 BACKGROUND: In this study, we evaluated the possibility that KRAS mutational status might be predictive of oxaliplatin (OXA) efficacy. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens